Article - 18/02/2013 Biotechnology in Biberach: a success story that breaks new ground At its New Year reception Biberach University of Applied Sciences outlined the universitys success the establishment of its biotechnology programme is going smoothly and student interest remains steady. Biberach also has a successful track record of acquiring third-party funding and has established new national and international cooperations.https://www.gesundheitsindustrie-bw.de/en/article/news/biotechnology-in-biberach-a-success-story-that-breaks-new-ground
Article - 23/08/2010 Signals that trigger symbiotic relationships Some fungi kill plants by wearing them down. Other fungi however are on friendly terms with plants. The research group led by Prof. Dr. Natalia Requena from the Karlsruhe Institute of Technology KIT investigates the molecular mechanisms that enable fungi and plants to initiate contact with each other. How do plants differentiate good from bad fungi? How do they manage to set up a functional and effective symbiotic relationship?https://www.gesundheitsindustrie-bw.de/en/article/news/signals-that-trigger-symbiotic-relationships
Article - 10/10/2016 Teva plans the large-scale production of monoclonal antibodies in Ulm Teva is investing heavily in its biotechnological production site in Ulm. On behalf of BIOPRO Baden-Württemberg, Walter Pytlik spoke with Dr. Hermann Allgaier, CEO of Teva Biotech, about the importance of biotechnology for the Group and about Teva in general. The company is headquartered in Israel.https://www.gesundheitsindustrie-bw.de/en/article/news/teva-plans-the-large-scale-production-of-monoclonal-antibodies-in-ulm
Article - 29/07/2013 Food supplements from blue-green algae do more harm than good Dietary supplements containing different types of algae claim to be rich in minerals that help improve mental acuity and concentration. While many of these products are neither useful nor harmful, products containing blue-green algae have raised serious concerns. Consumers have repeatedly complained about pain and discomfort after consumption. A study carried out by toxicologist Prof. Dr. Daniel Dietrich from the University of Konstanz has now…https://www.gesundheitsindustrie-bw.de/en/article/news/food-supplements-from-blue-green-algae-do-more-harm-than-good
Article - 21/05/2012 Interactions between the genome and the environment Parental neglect appears to lead to epigenetic changes in children, which result in behavioural problems in later years. This is one issue amongst the many that were addressed at the colloquium “Gene und Umwelt – Wie wir werden, was wir sind” (Genes and the environment – how we become what we are) recently organized by the Daimler and Benz Foundation in Berlin.https://www.gesundheitsindustrie-bw.de/en/article/news/interactions-between-the-genome-and-the-environment
Article - 16/01/2014 Kerstin Otte and her specific interest in tiny RNA molecules Molecular biologist Kerstin Otte is guided and inspired by content. This interest-based principle has brought Kerstin Otte to the Upper Swabian city of Biberach where she has found her professional niche. She has been professor of general molecular and cell biology at the Faculty of Pharmaceutical Biotechnology at Biberach University of Applied Sciences since 2006. She is currently specifically focussed on a class of small RNA molecules that…https://www.gesundheitsindustrie-bw.de/en/article/news/kerstin-otte-and-her-specific-interest-in-tiny-rna-molecules
Press release - 12/10/2011 Dioxin-like Chemical Messenger Makes Brain Tumors More Aggressive Scientists from German Cancer Research Center and Heidelberg University have discovered a new dioxin receptor-coupled metabolic pathway which weakens the immune system and promotes the growth of malignant gliomas. Glioma is the most frequent and most malignant brain tumor in adults. In Germany, about 4,500 people are newly diagnosed with glioma every year.https://www.gesundheitsindustrie-bw.de/en/article/press-release/dioxin-like-chemical-messenger-makes-brain-tumors-more-aggressive
Article - 04/03/2013 Genomic structural variations can cause cancer Genome-wide sequencing analyses show that comprehensive structural variations of chromosomes can play a key role in the pathogenesis of many types of cancer. Dr. Jan Korbel’s research group at the European Molecular Biology Laboratory in Heidelberg has been investigating chromosomal aberrations in paediatric brain tumours and early-onset prostate cancer.https://www.gesundheitsindustrie-bw.de/en/article/news/genomic-structural-variations-can-cause-cancer
Guest article - 22/09/2014 Experience report: Six months Shanghai Sebastian Giese, a doctoral student at the University of Freiburg, spent six months in Shanghai with funding from a Baden-Württemberg Ministry of Science, Research and the Arts China scholarship. Below, Sebastian tells us about his impressions of the country and its people and his experiences in the megacity.https://www.gesundheitsindustrie-bw.de/en/article/news/experience-report-six-months-shanghai
Article - 06/08/2009 PEPperPRINT wins award for its peptide chips PEPperPRINT GmbH, a spin-off of the German Cancer Research Centre, has won the Science4Life Venture Cup, a German start-up contest that comes with the most prize money. The Heidelberg-based start-up company was previously awarded the renowned research prize by the German Stifterverband and was chosen as a “Landmark in the Land of Ideas” competition run by the German government in 2009.https://www.gesundheitsindustrie-bw.de/en/article/news/pepperprint-wins-award-for-its-peptide-chips
Press release - 03/07/2009 Boehringer Ingelheim and Vitae Pharmaceuticals announce a collaboration to fight Alzheimer`s disease Boehringer Ingelheim and Vitae Pharmaceuticals Inc. announced today that they have entered into a significant worldwide collaboration to research and develop beta-secretase BACE inhibitors for the treatment of Alzheimers disease.https://www.gesundheitsindustrie-bw.de/en/article/press-release/boehringer-ingelheim-and-vitae-pharmaceuticals-announce-a-collaboration-to-fight-alzheimer-s-disease
Article - 28/01/2010 Liver cell transplantation for the treatment of innate urea cycle defects Liver transplantation is the only life-saving therapy available to patients suffering from genetic defects of the urea cycle. However, newborns cannot be transplanted with a donor liver. The injection of liver cell suspensions into the liver of sick babies through the portal vein can substitute the lack of enzyme activity, hence preventing brain damage until such time as liver transplantation becomes possible.https://www.gesundheitsindustrie-bw.de/en/article/news/liver-cell-transplantation-for-the-treatment-of-innate-urea-cycle-defects
Article - 16/02/2008 New test for the early diagnosis of cervical cancer mtm laboratories has launched the Cervatec assay for the early diagnosis of cervical cancer. The Cervatec assay will initially be commercialized as an adjunct to the Pap test for the screening of women aged 35 and younger.https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-test-for-the-early-diagnosis-of-cervical-cancer
Article - 24/10/2011 Ascendis Pharma: transient drug conjugates Ascendis Pharma’s proprietary technology platform, TransCon, is a novel prodrug technology for the production of new patentable versions of drugs already on the market, which has been developed for improving the dosage form and effect in patients. A Phase II clinical study of Ascendis Pharma’s most advanced drug candidate, a PEGylated growth hormone that only needs to be administered once-weekly to growth hormone-deficient adults, has recently…https://www.gesundheitsindustrie-bw.de/en/article/news/ascendis-pharma-transient-drug-conjugates
Article - 06/03/2011 Heidelberg Translational Lung Research Centre University and non-university research institutions in Heidelberg that carry out research into lung diseases have established an expert network – the Heidelberg Translational Lung Research Centre – which is part of the new BMBF-funded German Centre for Lung Research. In Heidelberg, research focuses on the development and treatment of cystic fibrosis, chronic obstructive pulmonary diseases and lung cancer. https://www.gesundheitsindustrie-bw.de/en/article/news/heidelberg-translational-lung-research-centre
Article - 13/12/2010 Christoph Kleineidam – communication without words Neuroethologist Dr. Christoph Kleineidam from the University of Konstanz focuses mainly on ants and their highly sensitive sensory system that allows them to communicate with each other by way of pheromones. He believes that these sensory mechanisms can be technologically implemented in the fields of thermosensor and chemosensor technology in the not-too-distant future.https://www.gesundheitsindustrie-bw.de/en/article/news/christoph-kleineidam-communication-without-words
Article - 24/11/2014 Lipid zipper triggers bacterial invasion Millions of people die each year from infections both in developing and industrial countries. There is still no effective treatment for a large number of diseases caused by pathogens. In order to treat infectious diseases effectively, we need to understand the mechanisms that bacteria use to infect human cells. The cytoskeleton of the host cell usually plays a key role in this process. Researchers at the University of Freiburg have discovered a…https://www.gesundheitsindustrie-bw.de/en/article/news/lipid-zipper-triggers-bacterial-invasion
Article - 02/12/2008 Cancer cells do not like rocket salad Isothiocyanates which are substances found in vegetables such as rocket kohlrabi or mustard promote good health. Dr. Evelyn Lamy and her team at the Freiburg University Hospital found out that isothiocyanates lead to considerably fewer DNA strand breaks.https://www.gesundheitsindustrie-bw.de/en/article/news/cancer-cells-do-not-like-rocket-salad
Article - 02/06/2010 Jens Timmer simulates dynamic processes in the cell Systems biology is growing in influence around the world. The cell is a dynamic network consisting of thousands of molecules that interact with each other. Only when scientists take into account these constantly changing patterns are they able to develop new ideas for drugs to treat certain disorders. Such developments require the contribution of theoretical physicists like Prof. Dr. Jens Timmer from the University of Freiburg. The researcher…https://www.gesundheitsindustrie-bw.de/en/article/news/jens-timmer-simulates-dynamic-processes-in-the-cell
Article - 20/04/2009 Anita Ignatius makes biomaterials smart Anita Ignatius is not interested in knowledge just for the sake of knowledge. “I have always been interested in the practical application of knowledge,” said the 45-year-old veterinarian. Highly theoretical courses she had to attend during her studies put an end to her dreams of opening her own practice after university. But this experience also had its advantages, because it helped her realise what she really wanted – namely doing research of…https://www.gesundheitsindustrie-bw.de/en/article/news/anita-ignatius-makes-biomaterials-smart
Article - 30/08/2008 Helpful toxins Sometimes a few nanogrammes of toxin are all that is needed to kill someone. Prof. Dr. Dr. Klaus Aktories from the Institute of Experimental and Clinical Pharmacy at the University of Freiburg is investigating why some bacterial toxins are so extremely toxic. Together with his team of researchers Aktories has identified the molecular mechanism of action of Clostridium difficile toxins. https://www.gesundheitsindustrie-bw.de/en/article/news/helpful-toxins
Press release - 25/11/2021 New Collaborative Research Centre at Ulm University Focusing on the factors that influence human aging After a highly competitive process Ulm University has been awarded its fifth Collaborative Research Centre (CRC). The new CRC 1506 ‘Aging at Interfaces’ addresses one of the most urgent medical challenges of our time: the aging of the human body and the diseases and constraints that are frequently associated with the aging process.https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-collaborative-research-centre-ulm-university-focusing-factors-influence-human-aging
Article - 19/04/2017 Are start-ups a matter for the boss? A professor’s thoughts on university spin-offs Research work and entrepreneurship are by no means mutually exclusive. There are numerous successful university spin-offs in the life sciences sector that prove this only too well. However, the road from a good idea to a commercially successful company can be long and arduous. Those who benefit from the support of their boss from the outset can consider themselves extremely fortunate. Prof. Dr. Hans-Georg Rammensee talks about his experience with…https://www.gesundheitsindustrie-bw.de/en/article/news/are-start-ups-a-matter-for-the-boss-a-professors-thoughts-on-university-spin-offs
Article - 13/11/2008 Ageing stem cells loose ability to adhere to stroma Hartmut Geiger a biochemist and stem cell researcher at Ulm University Hospital is using genetic methods to investigate the molecular basis of the physiological ageing of haematopoietic stem cells. After having spent a period in Cincinnati Geiger is currently head of the clinical research group Molecular and cellular ageing from the mechanisms of action to clinical perspectives.https://www.gesundheitsindustrie-bw.de/en/article/news/ageing-stem-cells-loose-ability-to-adhere-to-stroma